Interestingly, this study also showed that low Cav-1 expression in CAFs rather than in tumor cells predicts recurrence and survival in cancer patients, suggesting that loss of stromal Cav-1 heralds poor prognosis of gastric cancer patients, which is consistent with the finding in breast and prostate cancer [38, 39]. This evidence concerns the gene CAV1 and prostate carcinoma.